Sale!

LMNA Gene Lipodystrophy Type 2 Familial Partial Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The LMNA Gene Lipodystrophy Type 2 Familial Partial Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the LMNA gene, which are associated with Familial Partial Lipodystrophy Type 2 (FPLD2). FPLD2 is a rare genetic disorder characterized by the abnormal distribution of fat in the body, leading to a loss of subcutaneous fat in the limbs and trunk, while excess fat may accumulate in other areas, such as the face and neck. This condition can also lead to a variety of metabolic abnormalities, including insulin resistance, diabetes, hypertriglyceridemia, and an increased risk of cardiovascular disease.

The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any mutations in the LMNA gene. A positive result indicates a mutation in the LMNA gene that is known to cause FPLD2, providing crucial information for the diagnosis and management of the condition. This test is particularly useful for individuals showing symptoms of lipodystrophy or those with a family history of the condition, as it helps in confirming the diagnosis and facilitating early intervention strategies.

The cost of the LMNA Gene Lipodystrophy Type 2 Familial Partial Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity of the genetic analysis and the specialized technology required, this cost reflects the comprehensive nature of the test, ensuring accurate and reliable results. Individuals considering this test are encouraged to consult with a healthcare professional or genetic counselor to understand the implications of the test results and the best course of action based on those results.

Description

LMNA Gene Lipodystrophy Type 2 Familial Partial Genetic Test

Test Name: LMNA Gene Lipodystrophy Type 2 Familial Partial Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for LMNA Gene Lipodystrophy Type 2, Familial Partial NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Lipodystrophy Type 2, Familial Partial.

Test Details:

The LMNA gene is associated with a condition called familial partial lipodystrophy type 2 (FPLD2). Lipodystrophy refers to a group of rare disorders characterized by abnormal fat distribution in the body. FPLD2 specifically affects the distribution of subcutaneous fat, leading to fat loss in the limbs and buttocks while causing excess fat accumulation in the face and neck.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of FPLD2, NGS genetic testing can be used to identify mutations or variations in the LMNA gene, which can help confirm a diagnosis of familial partial lipodystrophy type 2.

By analyzing the LMNA gene through NGS, healthcare professionals can determine if there are any specific genetic changes that are responsible for the development of FPLD2. This information can be helpful in confirming a diagnosis, providing genetic counseling, and guiding treatment decisions for individuals with FPLD2.

Test Name	LMNA Gene Lipodystrophy type 2 familial partial Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for LMNA Gene Lipodystrophy type 2, familial partial NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Lipodystrophy type 2, familial partial
Test Details	The LMNA gene is associated with a condition called familial partial lipodystrophy type 2 (FPLD2). Lipodystrophy refers to a group of rare disorders characterized by abnormal fat distribution in the body. FPLD2 specifically affects the distribution of subcutaneous fat, leading to fat loss in the limbs and buttocks while causing excess fat accumulation in the face and neck. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of FPLD2, NGS genetic testing can be used to identify mutations or variations in the LMNA gene, which can help confirm a diagnosis of familial partial lipodystrophy type 2. By analyzing the LMNA gene through NGS, healthcare professionals can determine if there are any specific genetic changes that are responsible for the development of FPLD2. This information can be helpful in confirming a diagnosis, providing genetic counseling, and guiding treatment decisions for individuals with FPLD2.